Oral abstracts

ESVC – European Society of Veterinary Cardiology
Thursday 21 September
ESVC-O-1 09.00-09.15 Grosso Echocardiographic evaluation of main pulmonary artery and right pulmonary artery size in dogs with pulmonary hypertension
ESVC-O-2 09.15-09.30 Phetariyawong Left ventricular myocardial protein profile in dogs with myxomatous mitral valve disease and dilated cardiomyopathy
ESVC-O-17 09.30-09.45 Vezzosi The Mitral INsufficiency Echocardiographic (MINE) score in dogs with preclinical myxomatous mitral valve disease
ESVC-O-5 10.00-10.15 Sleeper Gene Therapy for the Treatment of Doberman Dilated Cardiomyopathy
ESVC-O-6 10.15-10.30 Carter Combined physical examination variables and N-terminal pro-brain natriuretic peptide in predicting cardiac disease in asymptomatic cats with murmurs
ESVC-O-7 11.20-11.35 Edgerton Investigation of the indications for and outcome of ambulatory electrocardiography in a referral population of dogs.
ESVC-O-8 11.35-11.50 Cala Transvenous closure of patent ductus arteriosus (PDA) with Nit-Occlud® occlusion system in nine dogs and one cat with a body weight less than 3 kg
ESVC-O-9 11.50-12.05 Liu Tetranectin as a Potential Biomarker for Feline Hypertrophic Cardiomyopathy
ESVC-O-10 12.05-12.20 Pierce Evaluation of the circulating renin-angiotensin-aldosterone system in healthy young dogs and dogs with right-sided congenital heart disease
ESVC-O-11 12.20-12.35 Escalda Assessment of heart rate in dogs with atrial fibrillation: Are two days better than one?
ESVC-O-12 12.35-12.50 Rogg Prevalence and progression of azotemia during treatment of congestive heart failure in cats
Friday 22 September
ESVC-O-13 14.25-14.40 Romito Clinical efficacy and tolerability of oral amiodarone and sotalol in dogs with tachyarrhythmias
ESVC-O-14 14.40-14.55 Goodrich Incidence of restenosis and associated risk factors in dogs undergoing balloon valvuloplasty for pulmonic stenosis
ESVC-O-15 14.55-15.10 Szatmari Do practicing veterinarians follow the ACVIM consensus guidelines for staging myxomatous mitral valve degeneration in dogs?
ESVC-O-16 15.10-15.25 Chang The Pulmonary hypertension Remodeling/hemodynamic-Induced Manifestations on Echocardiography (PRIME) score for predicting the severity of canine pulmonary hypertension
ESVC-O-3 15.25-15.40 Reimann Renin-angiotensin-aldosterone and phosphodiesterase system gene polymorphisms associated with congestive heart failure in Cavalier King Charles Spaniels with myxomatous mitral valve disease 
ESVC-O-18 15.40-15.55 Wong Left atrial rupture secondary to myxomatous mitral valve disease in 33 dogs (2017-2022)
ESVC-O-19 16.30-16.45 Van de Watering Ultrasonographic assessment of abdominal aortic flow to evaluate hemodynamic significance of left-to-right shunting patent ductus arteriosus in dogs
ESVC-O-20 16.45-17.00 McLaughlin Timing and patterns of resolution of lung ultrasound B-lines compared to  lung auscultation and respiratory rates in hospitalized dogs with cardiogenic pulmonary edema
ESVC-O-21 17.00-17.15 Climent-Pastor Use of intravenous nitroglycerin in the treatment of acute left-sided congestive heart failure in dogs and cats
ESVC-O-22 17.15-17.30 Szatmari How confident are practicing veterinarians in recognizing, and differentiating pathologic from innocent murmurs in puppies?
ESVC-O-23 17.30-17.45 Kramer Implantation of a novel transcatheter mitral valve in a pig heart model.
ESVC-O-24 17.45-18.00 Boz End-diastolic forward flow and restrictive physiology in dogs with pulmonary stenosis
SCH – Society of Comparative Hepatology 
Thursday 21 September
SCH-O-1 09.15-09.30 Proksch Cobalamin status derangements in dogs with portosystemic shunt
SCH-O-2 09.30-09.45 Da Silva Association between hyperlipidaemia and selected cholestatic markers in 75 dogs with suspect acute pancreatitis
SCH-O-3 09.45-10.00 Palizzotto Hepatic AA amyloidosis in shelter cats: clinico-pathological data and light microscopic findings
SCH-O-4 10.00-10.15 BEDEL Prevalence of canine cholangitis/cholangiohepatitis, a retrospective study based on 263 liver biopsy cases (2013-2021)
SCH-O-5 10.15-10.30 Dröes Point-of-care viscoelastometric evaluation of dogs with chronic hepatitis
ESVCP – European Society of Veterinary Clinical Pathology
Thursday 21 September
ESVCP-O-1 14.25-14.40 Frizzo Ramos Assessment of iron homeostasis and correlation of iron related parameters in healthy dogs
ESVCP-O-2 14.40-14.55 Mazzei Pleural effusion total nucleated cell count (TNCCpe), lactate dehydrogenase (LDHpe), total protein (TPpe) and their serum ratio (LDHratio and TPratio) in feline pleural fluids
ESVCP-O-3 14.55-15.10 Mazzei Discriminating transudates and exudates in cats with pleural effusion: comparison of diagnostic utility of Light’s criteria, simplified Light’s criteria and two traditional veterinary classification based on pleural effusion total protein (TPpe) and total nucleated cell count (TNCCpe)
ESVCP-O-4 15.10-15.25 Aroch The utility of feline serum amyloid a measured by immunoturbidimetry for diagnosing acute pancreatitis in cats
ESVCP-O-5 15.25-15.40 Zoia Evaluation of new strategies to classify canine pleural effusion 
ESVCP-O-6 15.40-15.55 Zoia Diagnostic values of amylase, adenosine deaminase and acute phase proteins in canine pleural exudates 
ESVCP-O-7 15.55-16.10 Cervone Lipiduria in dogs and cats: an incidental or pathological finding?
ESVCP-O-8 16.10-16.25  Molnár Development of a simple IFN-γ release whole blood assay for the assessment of Leishmania infantum specific cellular immunity in dogs
ESVCP-O-9 16.25-16.40  Proksch Reference intervals for evaluation of cobalamin status instead of sole cobalamin concentration in healthy dogs
ESVNU – European Society of Veterinary Nephrology and Urology
Thursday 21 September
ESVNU-O-1 09.00-09.15 Tang Risk factors and short-term implications associated with macroscopic nephrocalcinosis in cats with chronic kidney disease
ESVNU-O-2 09.15-09.30 Tang Pilot study evaluating the detection of nephrocalcinosis using ultrasonography in cats with chronic kidney disease
ESVNU-O-3 09.30-09.45 Pantaleo Evaluation of urinary podocin and nephrin as markers of podocyturia in dogs with leishmaniosis 
ESVNU-O-4 09.45-10.00 Pantaleo Evaluation of urinary amylase to creatinine ratio as a marker of renal damage in dogs with leishmaniosis undergoing conventional anti-Leishmania treatment
ESVNU-O-5 10.00-10.15 Jiwaganont Analysis of serum proteomic in cats with polycystic kidney disease-1 gene mutation
ESVNU-O-6 10.15-10.30 Bennett Progression of chronic kidney disease in cats following subcutaneous ureteral bypass device placement for ureteral obstruction compared to cats with idiopathic chronic kidney disease
ESVNU-O-7 11.20-11.35 Mourou Subcutaneous ureteral bypass placement is associated with a high complication rate but a prolonged survival in cats: a retrospective study of 94 cases (2014 – 2021)
ESVNU-O-8 11.35-11.50 Hardy ‘Interpretating discordant symmetric dimethylarginine and creatinine concentrations in relation to glomerular filtration rate
ESVNU-O-9 11.50-12.05 Hawes The neutrophil-to-lymphocyte ratio (NLR) in cats with chronic kidney disease (CKD)
Friday 22 September
ESVNU-O-10 09.00-09.15 Biscop Diagnostic value of cell cycle arrest biomarkers, tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor binding protein 7 (IGFBP7), to identify dogs with acute kidney injury 
ESVNU-O-11 09.15-09.30 Biscop Diagnostic value of urinary to serum neutrophil gelatinase-associated lipocalin (NGAL) ratio and fractional excretion of NGAL to differentiate dogs with acute kidney injury from healthy dogs, dogs with chronic kidney disease and critically ill dogs
ESVNU-O-12 09.30-09.45 Tagliasacchi Urinary neutrophil gelatinase-associated lipocalin (NGAL): A rapid lateral flow test in canine practice
ESVNU-O-13 09.45-10.00 Pichard Validation of a three-dimensional ultrasound device for non-invasive bladder volume measurement in dogs and cats
ESVNU-O-14 10.00-10.15 Pichard Genitourinary dysplasia in dogs and cats: A case series
ESVNU-O-15 10.15-10.30 Tang ACVIM Award Winning abstract: A Pilot Study to Identify Plasma Calciprotein Particles in Cats with Chronic Kidney Disease
ESCG – European Society of Comparative Gastroenterology
Friday 22 September
ESCG-O-1 09.00-09.15 Sung Fecal abundance of Prevotella copri, Ruminococcus gnavus, and Genus Collinsella in cats with chronic enteropathy
ESCG-O-2 09.15-09.30 Giordano Intestinal microbiota and fecal concentrations of fatty acids, sterols, and bile acids in cats with chronic enteropathy 
ESCG-O-3 09.30-09.45 Lyngby Association of serum and fecal microRNA profiles in healthy cats and cats with gastrointestinal cancer or chronic inflammatory enteropathy
ESCG-O-4 09.45-10.00 Simpson Serum metabolomic analysis of dogs with chronic enteropathies
ESCG-O-5 10.00-10.15 Cagnasso Investigation of fecal microbiome and metabolome perturbations in dogs with protein-losing enteropathy
ESCG-O-6 10.15-10.30 Vecchiato Fecal microbial transplantation effect on clinical outcome and fecal microbiota and metabolome in dogs with chronic enteropathy refractory to diet
ESCG-O-7 11.20-11.35 Huber Plasma proteome signatures of canine acute haemorrhagic diarrhoea syndrome (AHDS)
ESCG-O-8 11.35-11.50 Pilla Combined omeprazole and carprofen induced fecal dysbiosis and decreased short-chain fatty acid production in healthy dogs
ESCG-O-9 11.50-12.05 Siegrist Functional cobalamin deficiency (normal cobalamin with increased methylmalonic acid concentration) is uncommon in dogs.
ESCG-O-10 12.05-12.20 Tolbert Intestinal lymphangiectasia is a common finding in healthy soft-coated wheaten terriers
ESCG-O-11 12.20-12.35 Stavroulaki Early-life antibiotic exposure and susceptibility to chronic diarrhea during adulthood in cats.
ESCG-O-12 12.35-12.50 Remmel Congenital partial colonic agenesis in cats: clinical, biological, diagnostic imaging, endoscopic and histopathologic characterization. A retrospective study of 17 cases.
ESVIM – European Society of Veterinary Internal Medicine 
Saturday 23 September
ESVIM-O-1 14.25-14.40 Bailey Do dogs with either immune-mediated polyarthritis or steroid-responsive meningitis arteritis differ in their presentation and response to treatment compared to dogs with both diseases?  
ESVIM-O-2 14.40-14.55 Bergum Hjellegjerde Utility of screening diagnostic imaging in identifying potential triggers of associative immune-mediated polyarthritis (IMPA) in dogs.
ESVIM-O-3 14.55-15.10 Shalvey Evaluation of the Utility of Haematological Ratios as Biomarkers in Dogs with Forebrain Disease
ESVIM-O-4 15.10-15.25 Leynaud Epidemiological and hematological variables are useful to specify the underlying disease processes associated with feline non-regenerative anemia: a retrospective study of 440 cases (2018-2022)
ESVIM-O-5 15.25-15.40 Rösch Pharmacokinetics of orally administered immunosuppressive dosage of cyclosporine A over 10 days in healthy cats
ESVIM-O-6 15.40-15.55 Knies Prevalence of persistent hypertension and situational hypertension in a population of elderly cats in The Netherlands 
ESVIM-O-7 16.30-16.45 Mochel A Non-Invasive Model of Preclinical Metabolic Syndrome to Study the Effects of Sodium Glucose Transporter-2 Inhibitors in Dogs
ESVIM-O-8 16.45-17.00 Niinikoski Assessment of risk factors for sleep-disordered breathing in dogs
ESVIM-O-9 17.00-17.15 Langton ​​The comparison of sinonasal clotrimazole distribution using trephination or catheterisation in a cadaver study
ESVIM-O-10 17.15-17.30 Fastrès Lung microbiota assessment in dogs with bronchomalacia
ESVIM-O-11 17.30-17.45 Jaffey Clinical performance of a point-of-care Coccidioides antibody test to diagnose pulmonary coccidioidomycosis in dogs
ESVIM-O-12 17.45-18.00 Rizzoli Generation of a comprehensive molecular cell atlas of the healthy canine lung.
ISCAID - International Society for Companion Animal Infectious Diseases
Friday 22 September
ISCAID-O-1 08.00-08.15 Museux Update on the distribution and seasonal occurrence of vector-borne diseases in dogs in France
ISCAID-O-2 08.15-08.30 Elgueta Seropositivity to the louping ill flavivirus in dogs in the United Kingdom
ISCAID-O-3 08.30-08.45  Strobl Comparison of prognostic factors in feline panleukopenia in juvenile and adult cats
ISCAID-O-4 14.25-14.40 Weidinger Comparison of antibody response after feline panleukopenia virus vaccination in kittens with and without gastrointestinal parasitic infection
ISCAID-O-5 14.40-14.55 Evason Performance of a molecular diagnostic as compared to routine centrifugal-flotation for fecal gastrointestinal parasite identification 
ISCAID-O-7 15.10-15.25 Murillo Leishmania infantum-specific production of IL-2 in stimulated blood in dogs with different states of infection
ISCAID-O-9 15.25-15.40 Fernández Severe babesiosis in recently splenectomised dogs due to suspected or confirmed Babesia vulpes infection
ISCAID-O-10 16.30-16.45 Almendros Molecular detection of Babesia spp. in community and privately-owned cats in Hong Kong
ISCAID-O-11 16.45-17.00 Wenderlein Detection of pathogenic Leptospira spp. serogroups in Europe between 2017 and 2020 applying a gene-based molecular approach
ISCAID-O-12 17.00-17.15 Griebsch Serological evidence of exposure to Leptospira in dogs in Sydney, New South Wales, Australia
ISCAID-O-13 17.15-17.30 Tam Leptospira in community and privately-owned cats in Hong Kong: serology and urinary shedding 
ISCAID-O-14 17.30-17.45 Lutz Plasma procalcitonin and C-reactive protein in dogs with suspected bacterial pneumonia or non-bacterial pulmonary diseases  
ISCAID-O-15 17.45-18.00 Scahill Antimicrobial use in 6270 European dogs: a retrospective cohort study (2019-2021)
ESVONC – European Society of Veterinary Oncology
Friday 22 September
ESVONC-O-1 14.25-14.40 Žagar Biologic behaviour of canine preputial, scrotal and vulvar cutaneous mast cell tumours: a single-centre retrospective analysis of 102 dogs (2002-2022)
ESVONC-O-2 14.40-14.55 Loddo Canine large granular lymphocyte (LGL) lymphoma: A retrospective study of 42 cases.
ESVONC-O-3 14.55-15.10 Lecot Treatment and outcome of myeloma-related disorders in cats: a multicentric retrospective study of 50 cases
ESVONC-O-4 15.10-15.25 Chalfon Flow cytometry for detection and quantification of nodal metastasis in dogs with treatment-naïve firstly occurring cutaneous mast cell tumour
ESVONC-O-5 15.25-15.40 Ubiali Evaluation of programmed death-ligand 1 expression in canine lymphomas using flow cytometry
ESVONC-O-6 15.40-15.55 Lyseight Flow cytometry expression in canine T cell lymphoma; presentation, prognosis and response to lomustine-based protocols used in the naïve setting
ESVONC-O-7 16.30-16.45 Agnoli Peripheral blood and bone marrow involvement do not worsen outcome in 50 dogs with nodal peripheral t-cell lymphoma receiving alkylating-rich chemotherapy
ESVONC-O-8 16.45-17.00 Hawkes Comparison of first-line CHOP-19 and CHOP-25 in the treatment of canine aggressive peripheral nodal B-cell lymphomas: a European multicentric retrospective cohort study
ESVONC-O-9 17.00-17.15 Treggiari Incidence of gastrointestinal toxicity and treatment outcome in dogs with multicentric lymphoma receiving doxorubicin or epirubicin as part of a multi-agent chemotherapy protocol 
ESVONC-O-10 17.15-17.30 Scheemaeker Optimization of radioactive iodine uptake in canine thyroid carcinomas using recombinant human thyroid stimulating hormone
ESVONC-O-11 17.30-17.45 Guerra Serum lactate dehydrogenase acts as a potential prognostic biomarker of canine appendicular osteosarcoma
ESVONC-O-12 17.45-18.00 Capuano Investigation and description of circulating MicroRNAs in healthy and T-cell lymphoma-bearing dogs: a prospective, two-arm study
ESVE – European Society of Veterinary Endocrinology
Saturday 23 September
ESVE-O-1 08.00-08.15 Foale Induction of hepatic insulin production using AAV gene therapy in naturally-occuring canine diabetes mellitus; a potential future treatment?
ESVE-O-2 08.15-08.30 Tardo Effect of two diets on glycemic variability and glycemic control assessed by flash glucose monitoring system in diabetic dogs
ESVE-O-3 08.30-08.45 Niessen Efficacy and safety of once daily oral sodium-glucose co-transporter-2-inhibitor velagliflozin compared to twice daily insulin injection therapy in diabetic cats 
ESVE-O-4 09.00-09.15 Miceli Increased insulin-like growth factor 1 concentrations in a population of non-diabetic cats with overweight/obesity 
ESVE-O-5 09.15-09.30 Norman A genome-wide association study investigating the genetic basis of hyperthyroidism in domestic cats.
ESVE-O-6 09.30-09.45 Menzel Effect of duration of hyperthyroidism and degree of thyroid pathology on recovery of pituitary-thyroid axis and creatinine concentration in radioiodine-treated cats followed up over a 1-year period
ESVE-O-7 09.45-10.00 Williams Survival times of radioiodine treated hyperthyroid cats with and without iatrogenic hypothyroidism and investigation of effect of levothyroxine supplementation on survival time
ESVE-O-8 10.00-10.15 Travail Serum parathyroid hormone concentration as a predictor of post-operative hypocalcemia in dogs diagnosed of primary hyperparathyroidism and treated with parathyroidectomy
ESVE-O-9 10.15-10.30 van den Berg Metabolite profiling in canine pheochromocytomas, cortisol-secreting adrenocortical tumors, and normal adrenals
ESVE-O-10 11.20-11.35 Golinelli Addition of cabergoline to trilostane treatment for dogs with pituitary-dependent hypercortisolism
ESVE-O-11 11.35-11.50 Jankovic Electrophoretic patterns of proteinuria in dogs with Cushing’s syndrome and glomerular disease
ESVE-O-12 11.50-12.05 Fracassi Comparison of urinary cortisol and basal serum cortisol as a screening test for hypoadrenocorticism in dogs 
ESVE-O-13 12.05-12.20 Roberts Clinical findings, treatment and outcomes in cats with spontaneous hypoadrenocorticism: 41 cases
ESVE-O-14 12.20-12.35 Watson Identification of somatic mutations in feline adrenal tumours causing primary hyperaldosteronism
ESVE-O-15 12.35-12.50 Chamagne Evaluation of serum steroid profile in healthy cats, cats with chronic kidney disease and cats with primary hyperaldosteronism
ESVCN – European Society of Veterinary Comparative  Nutrition
Saturday 23 September
ESVCN-O-1 15.10-15.25 Dobenecker Short-term oral intake of inorganic phosphate additives causes an increase of FGF23 in cats and dogs
ESVCN-O-2 15.25-15.40 Blanchard Beneficial response to a very low-carbohydrate home-cooked diet in dogs with refractory chronic enteropathy: pilot study of 25 cases
ESVCN-O-3 15.40-15.55 Pignataro Follow-up in 167 homemade diets for maintenance and pathologic conditions in dog
ESVCN-O-4 15.55-16.10 Bela Effects of Lactobacillus reuteri NBF 2 DSM 32264 supplementation on healthy Certosino cat performance